After decades of political stigma, psychedelic therapies are moving into the medical spotlight as the FDA advances new pathways for psilocybin, methylone, and noribogaine research. AIRDATE: June 25, 2026
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.